Julie K. Klint

St. Lucia
QLD 4072, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Apo and ligand-bound high resolution Cryo-EM structures of the human Kv3.1 channel reveal a novel binding site for positive modulators.

Apo and ligand-bound high resolution Cryo-EM structures of the human Kv3.1 channel reveal a novel binding site for positive modulators.

Journal: PNAS nexus

Published: January 22, 2022

Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization.

Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization.

Journal: EJNMMI research

Published: February 20, 2020

Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile.

Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile.

Journal: Journal of medicinal chemistry

Published: November 21, 2019

Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.

Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.

Journal: Molecular pharmacology

Published: July 13, 2015

Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.

Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.

Journal: British journal of pharmacology

Published: July 03, 2014

From foe to friend: using animal toxins to investigate ion channel function.

From foe to friend: using animal toxins to investigate ion channel function.

Journal: Journal of molecular biology

Published: June 06, 2014

Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.

Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.

Journal: Biochemical pharmacology

Published: December 17, 2013

Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.

Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 02, 2013

Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.

Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.

Journal: PloS one

Published: January 25, 2013

Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.

Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: February 14, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026